Clinical Trials Browser

Phase 3 × Interventional × odanacatib × Clear all

NCT00691899 2016-08-12

A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)

Phase 3 Withdrawn

Prostatic Neoplasms